News
Influenza viruses are among the most likely triggers of future pandemics. A research team from the Helmholtz Center for Infection Research (HZI) and the Medical Center—University of Freiburg has ...
Studies show how spike protein changes determine the risk of viral outbreaks, offering important insights for the future ...
The ancestor of the virus that causes COVID-19 left its point of origin in Western China or Northern Laos just several years ...
Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.
Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...
Momentum is building for PROTAC treatments that eliminate disease-causing proteins, including those responsible for difficult ...
Yet, despite more than 20 years of study, the sweet receptor’s precise architecture remained elusive, even as scientists ...
The pigs will join a very short list of gene-modified animals that you can eat ANALYSIS | AGENCIES | Most pigs in the US are ...
Detailed Analysis Into the Regulatory Landscape, Patent Landscape, Key Trends, Clinical Trails, Pricing Analysis, Market Dynamics and MoreDublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Adult T-Cell ...
Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.
Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results